| Date | Title | Description |
| 03.04.2026 | Standing Ovation: €30M Fuels Global Dairy Protein Revolution | Standing Ovation secured €30 million in Series B funding. This capital fuels global scaling of its precision fermentation dairy proteins. The French company's patented technology transforms low-value whey permeates into high-quality casein.... |
| 02.04.2026 | Standing Ovation: $34.2 Million Raised For Precision Fermentation Dairy Protein Scale-Up | Standing Ovation has raised $34.2 million (€30 million) in a Series B funding round to accelerate the commercialization of its dairy proteins produced through precision fermentation. The round includes $28.5 million (€25 million) in equity ... |
| 31.03.2026 | Standing Ovation raises €30M to scale precision fermentation dairy proteins globally | French precision fermentation company Standing Ovation has announced a €30 million Series B financing round, including €25 million in equity, led jointly by the Ecotechnologies 2 fund — managed on behalf of the French government by Bpifranc... |
| 12.02.2026 | Kainova Therapeutics: C$32 Million Series B Raised For Immuno-Oncology Drug Development | Kainova Therapeutics has completed the first close of its Series B financing round, raising $32 million cad to advance its pipeline of GPCR-targeting therapies in immuno-oncology and inflammation. The financing was led by Investissement Qué... |
| 10.02.2026 | Kainova Therapeutics Raises $32M CAD in Series B Funding | Kainova Therapeutics, a Montreal, Canada-based clinical-stage biopharmaceutical company, raised $32 CAD in Series B funding.
The round was led by Investissement Québec and was supported by existing investors CTI Life Sciences, Panacea Ventu... |
| 23.01.2026 | ErVimmune Unlocks €17M for Groundbreaking Cancer Vaccine Trials | ErVimmune, a Lyon-based biotech, secured €17 million in Series A funding. This pivotal investment propels its innovative off-the-shelf cancer vaccine, ErVac01, into human clinical trials. The company pioneers therapeutic vaccines targeting ... |
| 21.01.2026 | ErVimmune: €17 Million Series A First Close To Advance Off-The-Shelf Cancer Vaccine Into The Clinic | ErVimmune, a Lyon, France-based biotechnology company developing next-generation therapeutic cancer vaccines targeting “unconventional” tumor antigens derived from human endogenous retroviruses (HERVs), has raised €17 million ($19.8 million... |
| 21.01.2026 | ErVimmune Raises €17M in Series A First Closing | ErVimmune, a Lyon, France-based biotechnology company developing new therapeutic vaccines, raised €17M in Series A funding.
Backers included Seventure Partners and SPRIM Global Investments.
The company intends to use the funds to further en... |
| 17.12.2025 | SkillCorner: $60 Million Growth Investment Raised To Scale AI Sports Tracking And Expand In North America | SkillCorner has secured a $60 million growth investment from Silversmith Capital Partners as the Paris-based sports analytics company looks to accelerate global expansion of its AI-driven tracking and contextual performance data across socc... |
| 03.11.2025 | Tubulis: Second Tranche Of €344 Million Series C Closed To Advance ADC Pipeline | Tubulis announced the second and final closing of its Series C financing round, bringing the total raised to €344 million ($401 million). The round included new investors Fidelity Management & Research Company, Janus Henderson Investors... |
| 15.10.2025 | Tubulis Raises €308M In Series C Funding | Tubulis, a Munich, Germany-based oncology company, closed a €308 million (USD 361m) Series C financing.
The round was led by Venrock Healthcare Capital Partners with participation from additional new investors Wellington Management and Asce... |
| 15.10.2025 | Tubulis: €308 Million Series C Secured To Advance Clinical Development Of Lead ADC Candidate TUB-040 | Tubulis announced the closing of a €308 million ($361 million) Series C financing round aimed at accelerating the clinical development of its lead antibody-drug conjugate (ADC) candidate, TUB-040. The round was led by Venrock Healthcare Cap... |
| 23.06.2025 | Enterome: $19 Million Secured To Fund Development Of OncoMimics Immunotherapy To Treat Follicular Lymphoma | Enterome, a clinical-stage company developing first-in-class OncoMimics immunotherapies to treat cancer, announced that it has raised $19 million in new private financing to advance its lead clinical program, EO2463 OncoMimics immunotherapy... |
| 07.03.2025 | +++ Outfittery +++ IDnow +++ Volocopter +++ Alphapet Ventures +++ Easelink +++ | Was gibt’s Neues? In unserem #StartupTicker liefern wir eine kompakte Übersicht über die wichtigsten Startup-Nachrichten des Tages (Freitag, 7. März). #STARTUPLAND
SAVE THE DATE: Am 5. November findet unsere zweite STARTUPLAND statt. Es erw... |
| 13.12.2024 | The Rise of Chief AI Officers: Navigating the New Corporate Landscape | In the corporate world, change is the only constant. Today, artificial intelligence (AI) is not just a tool; it’s a game-changer. The emergence of Chief AI Officers (CAIOs) is a testament to this shift. A recent study by Altrata reveals tha... |
| 13.12.2024 | bsport lands €30 million to develop wellness studio platform | Barcelona-based bsport, a platform for boutique wellness studios, has closed a €30 million Series B funding round led by Base10 Partners and Octopus Ventures.
The round also attracted participation from Stanford University and existing inve... |
| 13.12.2024 | bsport Raises €30M in Series B Funding | bsport, a Barcelona, Spain-based provider of a technology platform for the boutique wellness industry, raised €30M in Series B funding.
Backers included Base10 Partners (US) and Octopus Ventures (UK), alongside Stanford University and exist... |
| 18.10.2024 | Aenitis and Vay: Two Innovators Driving Change in Tech and Mobility | In the bustling world of technology and innovation, two companies stand out: Aenitis and Vay. Each is carving a niche in its respective field, showcasing the power of strategic funding and groundbreaking ideas. Aenitis, based in Paris, is r... |
| 14.10.2024 | Aenitis Raises Strategic Funding | Aenitis, a Paris, France-based acoustic-based cell manipulation company, raised a strategic founding of undisclosed amount.
Backers included European Innovation Council Fund advised by the European Investment Bank, Quadrivium I fund managed... |
| 25.09.2024 | Animab announces Jan Spaas as new Chairman of the Board | Zwijnaarde, Belgium – May 15, 2024: Animab, a front-runner in the field of highly innovative first-in-class oral antibody solutions for unmet needs in production animals, is excited to announce Jan Spaas joined the company’s board as Chairm... |
| 16.09.2024 | Standing Ovation Raises €3.75M in Series A+ Round, Appoints New CEO to Begin Animal-Free Casein Sales in 2025 | 4 Mins Read French precision fermentation startup Standing Ovation has raised €3.75M in a Series A extension and appointed a new CEO to begin selling its Advanced Casein next year.
Parisian food tech startup Standing Ovation is gearing up f... |
| 15.05.2024 | Allozymes: Pioneering Enzyme Innovation to Transform Industries Worldwide | Allozymes, a dynamic biotechnology startup based in Singapore, recently announced a significant milestone with the successful closure of a $15 million Series A funding round. This substantial investment, led by esteemed investors Seventure ... |
| 14.05.2024 | Allozymes Raises $15 Million in Series A Funding, Poised to Revolutionize Industries with Enzymatic Solutions | SINGAPORE, May 14, 2024 /PRNewswire/ -- Allozymes, a leading innovator in enzyme discovery and engineering, today announced the closing of a $15 million Series A funding round led by Seventure Partners of France and Xora Innovation of Singa... |
| 03.05.2024 | Karius Revolutionizes Infectious Disease Diagnostics with $100M Funding Boost | Karius, a genomic diagnostics powerhouse, has secured a whopping $100 million in Series C funding to expand its groundbreaking Karius Test. This test, a game-changer in infectious disease diagnosis, uses cutting-edge genomic analysis and AI... |
| 02.05.2024 | Karius Raises $100M in Series C Funding | Karius, Inc., a Redwood City, CA-based leader in genomic diagnostics for infectious disease, raised $100m in Series C funding.
The round was co-led by Khosla Ventures and new investors 5AM Ventures and Gilde Healthcare. Also investing was n... |
| 11.04.2024 | ID5 Secures $20 Million in Series B Funding | ID5, a leading identity provider for digital advertising, has successfully raised $20 million in its Series B funding round. This significant investment, the largest in the identity space to date, underscores ID5's pivotal role in driving t... |
| 10.04.2024 | ID5 announces $20 Million in Series B Funding | ID5, the market-leading identity provider for digital advertising, announced a Series B funding round of $20 million. This investment, the largest to date in the identity space, validates ID5’s key role in steering the industry forward duri... |
| 13.01.2021 | ‘Significant interest’: Venture capital major Seventure Partners extends €200m+ microbiome fund | European life sciences investment firm Seventure Partners has extended the final close of its second microbiome innovation fund and increased focus on advances in the skin... |
| 06.07.2017 | Seventure’s Health for Life Capital™ participates in $26.1m financing of Europe’s largest digital health provider, Push Doctor | Europe’s largest digital health provider, Push Doctor, announces that it has raised $26.1M in a Series B funding round led by Accelerated Digital Ventures (“ADV” – the... |
| 30.01.2017 | Skinjay Raises €3.5m in Funding | Skinjay, a Paris, France-based maker of shower micro-nebulization devices, raised €3.5m in funding.
The investor was Seventure Partners via its Health for Life Capital investment vehicle.
The company intends to use the funds to accelerate i... |
| 25.08.2016 | Mint Solutions Raises $5.6M Series B from Life Sciences Partners | Mint Solutions Holding BV, a private Dutch company developing and marketing the revolutionary medication safety system MedEye, has raised € 5 million in a Series B equity funding round led by the Brabant Development Agency (BOM Capital) and... |
| 10.07.2015 | Eligo Bioscience Raises €2M in Series A Funding | Eligo Bioscience, a Paris, France-based antibiotics maker, raised €2m in Series A funding.
The round was led by Seventure. In conjunction with the funding, Sebastien Groyer, Partner at Seventure, joined Eligo Bioscience’s board.
Led by Xavi... |
